Tumor Board Session 1: WHO Grade II Meningioma
18th February, 2023, 07:30 - 08:30
Tampa Bay 9
This session will be focused on reviewing current data to achieve a consensus on best practices for the management of WHO Grade II meningiomas, which is currently controversial. It will target students, residents, junior, and senior faculty members who manage patients with meningiomas.
Objectives
At the conclusion of this session, attendees will be able to:
- Diagnose and illustrate key radiographic and pathologic features of Grade II meningiomas.
- Discuss the role of molecular subtyping and methylation profiling in the characterization of Grade II meningiomas.
- Formulate a surgical approach and treatment plan for Grade II meningiomas.
- Evaluate the pros and cons of radiation treatment as an alternative to or adjunct to surgery for Grade II meningiomas.
Current Schedule
As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names
| Speaker | Title | Role | Times |
|---|---|---|---|
| Gelareh Zadeh 416-603-5679 / 416-634-8728 |
Moderator | - | |
| Ann Jay 7035829958 |
Moderator | - | |
| Gelareh Zadeh 416-603-5679 / 416-634-8728 |
Case Presentation | Speaker | 7:30 am - 7:40 am |
| Pablo Recinos 216-445-2901 |
Radiology Review - A Surgeon`s Perspective | Speaker | 7:40 am - 7:50 am |
| Carolina Benjamin 3052435932 |
Surgical Options and Choice of Approach | Speaker | 7:50 am - 8:00 am |
| Dukagjin Blakaj 614-366-2729 |
Role of Radiotherapy and Choice of Platform | Speaker | 8:00 am - 8:10 am |
| Stewart Neill 404-712-7320 |
Pathology Review (Including Molecular Subtyping and Methylation Profiling) | Speaker | 8:10 am - 8:20 am |
| |
Q&A | 8:20 am - 8:30 am |